Stockscreener 앱 받기
1.75
2.94%
0.05
전일 마감가:
$1.70
열려 있는:
$1.6025
하루 거래량:
22,449
Relative Volume:
0.31
시가총액:
$74.15M
수익:
$6.21M
순이익/손실:
$-19.92M
주가수익비율:
-1.6667
EPS:
-1.05
순현금흐름:
$-16.76M
1주 성능:
+0.57%
1개월 성능:
+10.76%
6개월 성능:
-30.00%
1년 성능:
-38.81%
1일 변동 폭
$1.6025
$1.78
1주일 범위
$1.6025
$1.8349
52주 변동 폭
$1.51
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
명칭
InspireMD Inc.
전화
972 3 6917691
주소
4 Menorat Hamaor Street, Tel Aviv
Compare NSPR vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
1.75 | 72.03M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-02 | 개시 | Maxim Group | Buy |
| 2016-01-07 | 개시 | Rodman & Renshaw | Buy |
| 2015-03-13 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2013-11-26 | 개시 | Oppenheimer | Outperform |
InspireMD Inc. 주식(NSPR)의 최신 뉴스
Can InspireMD Inc. outperform in the next rallyJuly 2025 Levels & Daily Chart Pattern Signal Reports - mfd.ru
Will InspireMD Inc. stock hit new highs in YEAR2025 Stock Rankings & Daily Profit Focused Stock Screening - mfd.ru
Aberdeen Group plc Expands Stake in InspireMD Inc with Strategic Acquisition - GuruFocus
Gains Report: Why is InspireMD Inc stock going upMarket Trend Summary & Daily Price Action Insights - baoquankhu1.vn
This Insider Has Just Sold Shares In InspireMD - simplywall.st
InspireMD (NYSE:NSPR) Now Covered by Maxim Group - Defense World
InspireMD CCO Gleason sells $99k in NSPR stock By Investing.com - Investing.com South Africa
InspireMD (NYSE:NSPR) Insider Shane Thomas Gleason Sells 8,411 Shares - MarketBeat
Shane Thomas Gleason Sells 17,593 Shares of InspireMD (NYSE:NSPR) Stock - MarketBeat
Shane Thomas Gleason Sells 12,395 Shares of InspireMD (NYSE:NSPR) Stock - MarketBeat
InspireMD CCO Gleason sells $99k in NSPR stock - Investing.com
Aug Spikes: Why is InspireMD Inc stock going upJuly 2025 Breakouts & High Accuracy Trade Alerts - baoquankhu1.vn
Rate Cut: Is InspireMD Inc part of any ETFJuly 2025 Movers & Precise Entry and Exit Recommendations - baoquankhu1.vn
Jobs Data: Why is InspireMD Inc stock going upBear Alert & Weekly Momentum Stock Picks - baoquankhu1.vn
InspireMD (NYSE:NSPR) versus Motus GI (NASDAQ:MOTS) Critical Contrast - Defense World
InspireMD (NYSE:NSPR) Stock Price Down 1.8%Should You Sell? - MarketBeat
One new InspireMD hire gets 36,118-share inducement grant - Stock Titan
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire Inc.
Performance Recap: Is M tron Industries Inc stock a good dividend stockDividend Hike & Fast Gain Stock Trading Tips - baoquankhu1.vn
Wall Street Recap: Can InspireMD Inc keep up with sector leadersVolume Spike & Consistent Return Strategy Ideas - baoquankhu1.vn
Buyback Watch: Is InspireMD Inc stock risky to hold nowQuarterly Portfolio Summary & High Accuracy Swing Trade Signals - baoquankhu1.vn
Options Flow: Can InspireMD Inc be recession proofJuly 2025 Intraday Action & Fast Moving Stock Watchlists - baoquankhu1.vn
InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC) - The Manila Times
InspireMD's CGuard® Prime Carotid Stent System Achieves Landmark Safety and Efficacy Results in C-GUARDIANS Trial Published in JACC - Quiver Quantitative
New carotid stent study reports low stroke rates for high-risk patients - Stock Titan
Chipmakers Recap: Can InspireMD Inc outperform in the next rally2025 Growth vs Value & Daily Chart Pattern Signals - baoquankhu1.vn
Published on: 2026-01-10 23:14:00 - Улправда
InspireMD (NASDAQ:NSPR) shareholders have endured a 81% loss from investing in the stock five years ago - Yahoo Finance
Will InspireMD Inc. (II2) stock outperform value peersProfit Target & Expert Approved Momentum Trade Ideas - Улправда
Why InspireMD Inc. stock could be next big winnerPortfolio Performance Report & Growth Focused Stock Reports - ulpravda.ru
Will InspireMD Inc. stock continue dividend increasesMarket Growth Report & Advanced Technical Signal Analysis - Улправда
Will InspireMD Inc. (II2) stock benefit from sector leadership2025 Macro Impact & Weekly Return Optimization Alerts - Улправда
How InspireMD Inc. stock compares to growth peersTrade Exit Summary & Daily Entry Point Trade Alerts - Улправда
InspireMD (NYSE:NSPR) Trading Down 6.2%Should You Sell? - MarketBeat
InspireMD (NYSE:NSPR) Trading Down 6.2% – Should You Sell? - Defense World
InspireMD (NSPR) price target decreased by 11.11% to 4.08 - MSN
Head to Head Analysis: InspireMD (NYSE:NSPR) versus Minerva Surgical (NASDAQ:UTRS) - Defense World
Is InspireMD (NASDAQ:NSPR) In A Good Position To Invest In Growth? - Sahm
Will InspireMD Inc. stock gain from lower inflationWeekly Trade Analysis & Low Risk Entry Point Guides - Улправда
Working capital per share of InspireMD Inc. – DUS:II2 - TradingView — Track All Markets
Can InspireMD Inc. stock hit record highs again2025 Breakouts & Breakdowns & Stepwise Swing Trade Plans - Улправда
Aug Update: Will InspireMD Inc. (II2) stock outperform value peersJuly 2025 Catalysts & Safe Capital Preservation Plans - Улправда
Why InspireMD Inc. stock is considered a top pickJuly 2025 Highlights & Weekly High Return Forecasts - Улправда
Will InspireMD Inc. (II2) stock profit from fiscal stimulusBreakout Watch & Verified Momentum Watchlists - Улправда
InspireMD’s new study on neuroprotection system: A potential game-changer? - MSN
Is InspireMD Inc a good long term investmentREITs Market Trends & Capital Efficiency Improvement - earlytimes.in
InspireMD’s Pivotal Study on CGuard Prime Stent System: A Potential Game-Changer - MSN
InspireMD Inc. (NSPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.33%
0.51%
자본화:
|
볼륨(24시간):